WHO Expert Committee on Specifications for Pharmaceutical Preparations - WHO Technical Report Series, No. 834 - Thirty-third Report
(1993; 36 pages) View the PDF document
Table of Contents
View the documentWHO Expert Committee on Specifications for Pharmaceutical Preparations
View the document1. Introduction
Open this folder and view contents2. The international pharmacopoeia and related activities
Open this folder and view contents3. International Chemical Reference Substances and International Infrared Reference Spectra
View the document4. Quality control methods for medicinal plant materials
View the document5. The WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Open this folder and view contents6. Good manufacturing practices for pharmaceutical products
View the document7. Development of globally acceptable standards for excipients
Open this folder and view contents8. Stability of dosage forms
View the document9. Simple test methodology
View the document10. Quality assurance in pharmaceutical supply systems
Open this folder and view contents11. Pharmaceutical production in developing countries
View the document12. Training
View the documentAcknowledgements
View the documentReferences
View the documentAnnex 1 - List of available International Chemical Reference Substances1
View the documentAnnex 2 - List of available International Infrared Reference Spectra
Close this folderAnnex 3 - Good manufacturing practices for biological products1
View the document1. Scope of these guidelines
View the document2. Principles
View the document3. Personnel
View the document4. Premises and equipment
View the document5. Animal quarters and care1
View the document6. Production
View the document7. Labelling
View the document8. Lot processing records (protocols) and distribution records
View the document9. Quality assurance and quality control
View the documentAuthors
View the documentAcknowledgements
View the documentReferences
View the documentBack Cover
 

References

1. Good manufacturing practices for pharmaceutical products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second Report. Geneva, World Health Organization, 1992 (WHO Technical Report Series, No. 823), Annex 1.

2. WHO Expert Committee on Biological Standardization. Forty-second Report. Geneva, World Health Organization, 1992 (WHO Technical Report Series, No. 822).

3. Laboratory biosafety manual, 2nd ed. Geneva, World Health Organization, 1993.

4. Quality management for chemical safety testing. Geneva, World Health Organization, 1992 (Environmental Health Criteria, No. 141).

5. WHO Expert Committee on Biological Standardization. Fortieth Report. Geneva, World Health Organization, 1990 (WHO Technical Report Series, No. 800), Annex 1.

SELECTED WHO PUBLICATIONS OF RELATED INTEREST

The international pharmacopoeia, third edition.

Price (Sw.fr.)*

Volume 1: general methods of analysis. 1979 (223 pages)

24-

Volume 2: quality specifications. 1981 (342 pages)

36-

Volume 3: quality specifications. 1988 (407 pages)

64-

Basic tests for pharmaceutical dosage forms.
1991 (v + 129 pages)

24.-

Basic tests for pharmaceutical substances.
1986 (205 pages)

34.-

WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Thirty-second report.
WHO Technical Report Series, No. 823, 1992 (vi + 134 pages)

17.-

The use of essential drugs.
Fifth report of the Expert Committee.
WHO Technical Report Series, No. 825, 1992 (iv + 75 pages)

10.-

International nonproprietary names (INN) for pharmaceutical substances.
Cumulative list No. 8.
1992 (xlvi + 692 pages)

140-

Biological substances: International Standards and Reference Reagents, 1990.
1991 (105 pages)

19-

Guidelines for developing national drug policies.
1988 (iv + 52 pages)

11-

Ethical criteria for medicinal drug promotion.
1988 (16 pages)

8.-

WHO Expert Committee on Biological Standardization.
Forty-second report. WHO Technical Report Series, No. 822, 1992 (v + 84 pages)

12-

WHO Expert Committee on Biological Standardization.
Forty-first report. WHO Technical Report Series, No. 814, 1991 (v + 79 pages)

11.-

 

* Prices in developing countries are 70% of those listed here.


Further information on these and other WHO publications can be obtained from
Distribution and Sales, World Health Organization, 1211 Geneva 27, Switzerland

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014